SIGNIFICANCE OF 2 POINT MUTATIONS PRESENT IN EACH HEXB ALLELE OF PATIENTS WITH ADULT G(M2) GANGLIOSIDOSIS (SANDHOFF DISEASE) - HOMOZYGOSITYFOR THE ILE(207)-]VAL SUBSTITUTION IS NOT ASSOCIATED WITH A CLINICAL OR BIOCHEMICAL PHENOTYPE
I. Redonnetvernhet et al., SIGNIFICANCE OF 2 POINT MUTATIONS PRESENT IN EACH HEXB ALLELE OF PATIENTS WITH ADULT G(M2) GANGLIOSIDOSIS (SANDHOFF DISEASE) - HOMOZYGOSITYFOR THE ILE(207)-]VAL SUBSTITUTION IS NOT ASSOCIATED WITH A CLINICAL OR BIOCHEMICAL PHENOTYPE, Biochimica et biophysica acta. Molecular basis of disease, 1317(2), 1996, pp. 127-133
The molecular defects in the HEXB gene encoding the common beta-subuni
t of lysosomal P-hexosaminidase At beta-Hex A, alpha beta) and beta-He
x B (beta beta) were investigated in a Portuguese family affected with
late onset Sandhoff disease (G(M2)-gangliosidosis variant 0). This fa
mily comprised two unaffected daughters and three affected sibs who de
veloped at about age 17 cerebellar ataxia and mental deficiency. Their
parents were consanguineous and clinically asymptomatic. There was no
detectable beta-Hex B activity and a profound reduction in the activi
ty of beta-Hex A in the leukocytes and transformed lymphoid cell lines
from the affected sibs. The expected intermediate values were observe
d in the parents as well as in one daughter and her children. Western
analysis revealed the presence of reduced, but detectable amounts of m
ature beta-chain protein in cell lysates from the probands and interme
diate levels in the parents. Nucleotide sequencing of amplified, rever
se-transcribed beta-chain mRNA demonstrated the presence of two single
point mutations: an A(619) to G transition in exon 5 (Ile(207)-->Val)
, and a G(1514) to A transition in exon 13 (Arg(505)-->Gln). Both of t
hese two mutations have been previously linked to the adult form of Sa
ndhoff disease in compound heterozygote patients, All three affected s
ibs were found to be homoallelic for both mutations. Interestingly, wh
ile the mother was heterozygous for each mutation, the father was homo
zygote for the A(619)-->G substitution and heterozygote for the G(1514
)-->A transition. Since the father is homozygote for the A(619)-->G mu
tation but expresses a biochemical phenotype consistent with a carrier
of Sandhoff disease and is clinically asymptomatic, this substitution
is likely a neutral mutation. We confirmed this hypothesis by finding
this transition present in 4 of 30 alleles from normal individuals. W
e conclude that homozygosity for the G(1514)-->A mutation is exclusive
ly responsible for the adult form of Sandhoff disease in this family,
and that the A(619)-->G substitution is not a deleterious mutation but
rather a common HEXB polymorphism.